Loading clinical trials...
Loading clinical trials...
A Parallel-group Treatment, 2-arm Study to Compare the Efficacy and Safety of Follitropin Alfa and Lutropin Alfa Fixed Dose Combination Versus hMG for Inducing Follicular Development in Japanese Participants With LH and FSH Deficiency Undergoing ART
Conditions
Interventions
Follitropin alfa/lutropin alfa (MBJ-0011)
hMG
+3 more
Locations
10
Japan
Kameda IVF Clinic Makuhari - Dept of Obstetrics/Gynecology
Chiba, Chiba, Japan
YOKOTA Maternity Hospital - Dept of Reproductive Medical Gynecology
Maebashi, Gunma, Japan
Kamiya Ladies Clinic - Dept of Gynecology
Sapporo, Hokkaido, Japan
Hanabusa Women's Clinic Hanabusa Women's Central Fertility Clinic - Dept of Obstetrics/Gynecology
Kobe, Hyōgo, Japan
Sophia Ladies Clinic - Dept of Obstetrics/Gynecology
Sagamihara-shi, Kanagawa, Japan
Ladies Clinic Cosmos - Dept of Infertility Treatment
Kochi, Kochi, Japan
Start Date
February 5, 2026
Primary Completion Date
October 31, 2028
Completion Date
June 30, 2029
Last Updated
March 18, 2026
NCT07542626
NCT07499804
NCT06826365
NCT07471373
NCT07153367
NCT04872660
Lead Sponsor
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions